Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines
Study sponsor: Novavax
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-04-01Actual
Enrollment · participants400Actual
Source updated2025-07-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.